Email This Article
Headlines & Perspectives
Amylin, Eli Lilly to Address Byetta Concerns
By
Elizabeth Trotta
08/25/08 - 06:28 PM EDT
The drugmakers schedule a 5 p.m. call on Tuesday to discuss the diabetes treatment, the center of a frenzy last week after regulators said it 'could' be linked to two deaths.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,414.14 | 1,107.81 | 2,197.75 | 34.42 |
Oil *
76.76
|
|
UP
25.24
|
UP
1.83
|
UP
3.40
|
DOWN
0.41
|
10 Yr
3.44%
SPDR Gold
111.98
|
|
+0.24%
|
+0.17%
|
+0.15%
|
-1.18%
|
Data delayed 20 minutes |


Connect with TheStreet